“YX2401K” has been included in the key variety service list Recently, Beletalent (ZHUHAI) Pharmaceutical Co., Ltd. received a notice from the […]
Case of “Tangning Tongluo Tablets” Exempted from Phase II Clinical Trials Shared On November 21, 2024, the 15th special report
Tangning Tongluo Tablets Approved to Directly Conduct Phase III Clinical Trials On November 12, Beletalent (ZHUHAI) Pharmaceutical Co., Ltd.（hereinafter referred to as Beletalent） received
Founded in 2023, located in Hengqin, Guangdong Province, China, Guangdong-Macau Deep Cooperation Zone, a science and technology-based pharmaceutical enterprise specializing in innovative drug research, industrialization and international trade.
